EIHSX Mutual Fund

NAV$13.82

Fund Essentials - as of Feb 28, 2026

Net Assets
$162M
Expense Ratio
0.93%
Dividend Yield (Current)
7.37%
Holdings
44
Inception Date
Oct 1, 2009
Fund Family
Eaton Vance
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD-0.58%
1 Year+11.08%
3 Year+5.47%
5 Year+4.15%
10 Year+8.51%

Asset Allocation

Stocks: 99.97%
Other: 0.03%

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co11.33%
ABBVAbbvie Inc6.66%
AZN:LNAstraZeneca PLC6.54%
JNJJohnson & Johnson6.28%
ROG:SMRoche Holding Ag5.85%
Top 10 Concentration: 55.71%Report Date: Feb 28, 2026
Download all 44 holdings for EIHSX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
7.37%
Frequency
Annually
Latest Distribution
$1.24
-

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

EIHSX Mutual Fund Overview

EIHSX Mutual Fund (Eaton Vance Worldwide Health Sciences Fund Class I) is managed by Eaton Vance with $161.9M in net assets. EIHSX expense ratio is 0.93%, holding 44 positions across sectors including Health Care, Unknown, Financials. Inception date: 2009-10-01.

EIHSX performance shows a YTD return of -0.58%. The 1-year return is 11.08% and the 5-year return is 4.15%. EIHSX dividend yield stands at 7.37%, paid annually.

EIHSX top holdings include Eli Lilly & Co (11.3%), Abbvie Inc (6.7%), AstraZeneca PLC (6.5%), Johnson & Johnson (6.3%), Roche Holding Ag (5.8%). View all EIHSX holdings, sector breakdown, or dividend history.

EIHSX can be compared against other funds using the overlap calculator or side-by-side comparison tool. EIHSX alternatives are available via the screener, along with tax-loss harvesting opportunities.